Replies to post #753969 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

Increasing capacity means new areas under development or finished fitting out of current suites at Advent right? New areas would have been fitted out with fully digitized Flaskworks processors as well as any additional processors used for manufacturing. The recent inspection of the facility and certification of the finished 1b buildout area likely had Flaskworks processors installed for comparability studies and possibly also had the choice of manufacturing equipment for Direct installed and approved as well to have a basic starting point for any clinical trial. This would have entailed a significant amount of very expensive finishing work before any inspection. Is this what you are suggesting has been done? Best wishes

I don't know any details. That is also because I really do not care about a company that is not owned by NorthWest so I couldn't be bothered and Im therefore not trying to find out.